| Title |
Safety and efficacy of progressive resistance training in breast cancer: a systematic review and meta-analysis
|
|---|---|
| Published in |
Breast Cancer Research and Treatment, October 2014
|
| DOI | 10.1007/s10549-014-3162-9 |
| Pubmed ID | |
| Authors |
Birinder S. Cheema, Sharon L. Kilbreath, Paul P. Fahey, Geoffrey P. Delaney, Evan Atlantis |
| Abstract |
The purpose of this study was to assess the safety and efficacy of progressive resistance training (PRT) in breast cancer. Randomized controlled trials (RCTs) published to November 2013 that reported on the effects of PRT (>6 weeks) on breast cancer-related lymphedema (BCRL) (incidence/exacerbation, arm volume, and symptom severity), physical functioning (upper and lower body muscular strength), and health-related quality of life (HRQoL) in breast cancer patients were included. Of 446 citations retrieved, 15 RCTs in 1,652 patients were included and yielded five studies on BCRL incidence/exacerbation (N = 647), four studies on arm volume (N = 384) and BCRL symptom severity (N = 479), 11 studies on upper body muscular strength (N = 1,252), nine studies on lower body muscular strength (N = 1,079), and seven studies on HRQoL (N = 823). PRT reduced the risk of BCRL versus control conditions [OR = 0.53 (95 % CI 0.31-0.90); I (2) = 0 %] and did not worsen arm volume or symptom severity (both SMD = -0.07). PRT significantly improved upper [SMD = 0.57 (95 % CI 0.37-0.76); I (2) = 58.4 %] and lower body muscular strength [SMD = 0.48 (95 % CI 0.30-0.67); I (2) = 46.7 %] but not HRQoL [SMD = 0.17 (95 % CI -0.03 to 0.38); I (2) = 47.0 %]. The effect of PRT on HRQoL became significant in our sensitivity analysis when two studies conducted during adjuvant chemotherapy [SMD = 0.30 (95 % CI 0.04-0.55), I (2) = 37.0 %] were excluded. These data indicate that PRT improves physical functioning and reduces the risk of BCRL. Clinical practice guidelines should be updated to inform clinicians on the benefits of PRT in this cohort. |
X Demographics
The data shown below were collected from the profiles of 29 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 4 | 14% |
| United States | 3 | 10% |
| Canada | 3 | 10% |
| United Kingdom | 3 | 10% |
| Norway | 2 | 7% |
| Turkey | 1 | 3% |
| Australia | 1 | 3% |
| Germany | 1 | 3% |
| Finland | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 9 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 19 | 66% |
| Scientists | 7 | 24% |
| Practitioners (doctors, other healthcare professionals) | 3 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 250 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Malaysia | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 248 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 37 | 15% |
| Researcher | 29 | 12% |
| Student > Bachelor | 27 | 11% |
| Student > Ph. D. Student | 26 | 10% |
| Other | 15 | 6% |
| Other | 44 | 18% |
| Unknown | 72 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 58 | 23% |
| Nursing and Health Professions | 40 | 16% |
| Sports and Recreations | 39 | 16% |
| Psychology | 5 | 2% |
| Social Sciences | 5 | 2% |
| Other | 21 | 8% |
| Unknown | 82 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2021.
All research outputs
#1,888,651
of 25,853,983 outputs
Outputs from Breast Cancer Research and Treatment
#233
of 5,012 outputs
Outputs of similar age
#20,803
of 272,394 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#4
of 55 outputs
Altmetric has tracked 25,853,983 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,012 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 272,394 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.